Tencent & Alibaba chase remittances in battle for Southeast Asia

Technology

Aphria closes deal, now worth up to $300 million, to acquire Scythian’s Latin American assets

Cannabis, Life Science

Lilly Licenses Chugai Pharma’s Oral Diabetes Drug for $50 Million Upfront

Life Science

Evoke Acquires Navience Healthcare Solutions, LLC

Life Science

Fosun Pharma Acquires China Rights to Stroke Drug in $32.5 Million Agreement

Life Science

I-Mab Biopharma Expands Strategic Collaboration with WuXi Biologics and Licenses WuXiBody™ Platform for Three Bispecific Antibody Programs

Life Science

Aurora Cannabis revenues more than triples to $19.1 million in fourth quarter

Cannabis, Life Science

British Biologicals’ USA Leadership Team Equipped for Launch of NEW California Based Operating Facility

Life Science

Kalorama Information Reports IVD Markets in China, South Korea and Vietnam Reach $3.7 Billion

Life Science

MeMed Raises Over $70 Million to Advance Pioneering Point-Of-Care Platform and Immune-Based Test for Distinguishing Bacterial Versus Viral Infections

Life Science

Changchun High & New Forms $200 Million Biosimilar JV with Alvotech of Iceland

Life Science

China Medical In-Licenses China Rights to VAXIMM’s Immunotherapies

Life Science

WuXi AppTec Files for $1 Billion-Plus IPO in Hong Kong

Life Science

Digital China Health to Promote Genomics Diagnostic Support System in China

Life Science

Warburg Pincus Invests $800M In Chinese Logistics Firm NewEase China

Technology